Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (31)
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
1979 • 22,482 citations
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
1980 • 8,711 citations
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
1993 • 3,465 citations
The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
1991 • 3,396 citations
Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species
1993 • 1,692 citations
Programmed cell death involved in the schizolysigenous formation of the secretory cavity in Citrus sinensis L. (Osbeck)
2010 • 1,629 citations
The c-fos protein interacts with c-JunAP-1 to stimulate transcription of AP-1 responsive genes
1988 • 1,352 citations
Oncogene jun encodes a sequence-specific trans- activator similar to AP-1
1988 • 940 citations
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
1993 • 898 citations
Continuous c-fos expression precedes programmed cell death in vivo
1993 • 784 citations
The jun and fos protein families are both required for cell cycle progression in fibroblasts.
1991 • 442 citations
Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines.
1992 • 401 citations
Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
1994 • 280 citations
Inhibition of DNA Fragmentation in Thymocytes and Isolated Thymocyte Nuclei by Agents That Stimulate Protein Kinase C
1989 • 276 citations
Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells.
1993 • 273 citations
bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways.
1993 • 238 citations
bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair.
1993 • 218 citations
Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-D-arabinofuranosylcytosine.
1991 • 198 citations
Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinases
1992 • 134 citations
Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[β-d-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells
1994 • 86 citations
Apoptosis or Programmed Cell Death
1991 • 79 citations
Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide.
1991 • 74 citations
cis-Diamminedichloroplatinum(II) induces c-jun expression in human myeloid leukemia cells: potential involvement of a protein kinase C-dependent signaling pathway.
1992 • 72 citations
Camptothecin and its derivatives induce expression of the c-jun protooncogene in human myeloid leukemia cells.
1991 • 66 citations
Differential regulation of c-fos, fosB, c-jun, junB, bcl-2 and bax expression in rat skin following single or chronic ultraviolet irradiation and in vivo modulation by antisense oligodeoxynucleotide superfusion.
1994 • 63 citations
Transient mitotic phase localization of bcl-2 oncoprotein in human carcinoma cells and its possible role in prevention of apoptosis.
1994 • 58 citations
Regulation of c-jun gene expression in HL-60 leukemia cells by 1-.beta.-D-arabinofuranosylcytosine. Potential involvement of a protein kinase C dependent mechanism
1991 • 54 citations
Prolonged expression of c-jun and associated activity of the transcription factor AP-1, during apoptosis in a human leukaemic cell line.
1994 • 49 citations
Protein kinase C modulation.
1992 • 38 citations
Amplified expression of three jun family members inhibits erythroleukemia differentiation
1990 • 28 citations
Enhancement of the Antiproliferative Effect of cis-Diamminedichloroplatinum (II) and Other Antitumor Agents by Inhibitors of Enzymes Involved in Growth Factor Signal-Transduction
1991 • 8 citations